Global Infertility Services Competitive Landscape Professional Research Report 2024

Global Infertility Services Competitive Landscape Professional Research Report 2024

Research Summary

Infertility services encompass a range of medical treatments and procedures aimed at assisting individuals or couples who have difficulty conceiving a child. These services address various causes of infertility, such as hormonal imbalances, reproductive tract abnormalities, ovulatory disorders, or sperm-related issues. Common infertility treatments include fertility medications to stimulate ovulation, intrauterine insemination (IUI) where sperm is directly placed into the uterus, and assisted reproductive technologies (ART) like in vitro fertilization (IVF), where eggs and sperm are combined outside the body and then implanted into the uterus. Additionally, advanced techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and donor egg or sperm options are available for specific cases. Infertility services often involve comprehensive evaluations, personalized treatment plans, and supportive care to help individuals or couples achieve their goal of starting or expanding their family.

According to DIResearch's in-depth investigation and research, the global Infertility Services market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Infertility Services include CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, Xytex Cryo International etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Infertility Services. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Infertility Services market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Infertility Services market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Infertility Services industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Infertility Services Include:

CARE facility

CooperSurgical

Ferring Pharmaceuticals

Monash IVF

Merck

Vitrolife

AbbVie

Apricus Biosciences

AstraZeneca

Auxogyn

Eli Lilly

EMD Serono

IKS International

InVitro Care

INVO Bioscience

Irvine Scientific

LifeGlobal

MedITEX

NMC Health

OB GYN Associates

OvaScience

Pantec Biosolutions

Reproductive Medicine Associates of New Jersey

The Sims Clinic

TriHealth

Virtus Health

Xytex Cryo International

Infertility Services Product Segment Include:

Assisted Reproductive Technology (ART)

Infertility Drug Services

Others

Infertility Services Product Application Include:

Male

Female

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Infertility Services Industry PESTEL Analysis

Chapter 3: Global Infertility Services Industry Porter’s Five Forces Analysis

Chapter 4: Global Infertility Services Major Regional Market Size and Forecast Analysis

Chapter 5: Global Infertility Services Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Infertility Services Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Infertility Services Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources